Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy.
Esposito G, Perrino C, Cannavo A, Schiattarella GG, Borgia F, Sannino A, Pironti G, Gargiulo G, Di Serafino L, Franzone A, Scudiero L, Grieco P, Indolfi C, Chiariello M. Esposito G, et al. Among authors: borgia f. Basic Res Cardiol. 2011 Jun;106(4):577-89. doi: 10.1007/s00395-011-0163-2. Epub 2011 Mar 3. Basic Res Cardiol. 2011. PMID: 21369867
Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials.
Bagai A, Tan M, Di Mario C, Halvorsen S, Cantor WJ, Le May MR, Fernandez-Aviles F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sánchez PL, Westerhout CM, Goodman SG, Yan AT. Bagai A, et al. Among authors: borgia f. Am Heart J. 2014 Nov;168(5):757-65. doi: 10.1016/j.ahj.2014.07.027. Epub 2014 Aug 7. Am Heart J. 2014. PMID: 25440805
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials.
Madan M, Halvorsen S, Di Mario C, Tan M, Westerhout CM, Cantor WJ, Le May MR, Borgia F, Piscione F, Scheller B, Armstrong PW, Fernandez-Aviles F, Sanchez PL, Graham JJ, Yan AT, Goodman SG. Madan M, et al. Among authors: borgia f. JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):166-174. doi: 10.1016/j.jcin.2014.09.005. Epub 2014 Oct 31. JACC Cardiovasc Interv. 2015. PMID: 25616922 Free article.
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry.
Moscarella E, Varricchio A, Stabile E, Franzone A, Granata F, Rapacciuolo A, Galasso G, Capozzolo C, Cirillo P, Monda V, Monterforte I, Borgia F, Piro O, Bonzani G, Trimarco B, Esposito G. Moscarella E, et al. Among authors: borgia f. Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):401-5. doi: 10.1016/j.carrev.2015.07.008. Epub 2015 Aug 10. Cardiovasc Revasc Med. 2015. PMID: 26342404
Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials.
Graham JJ, Yan AT, Tan MK, Cantor WJ, DiMario C, Jolly SS, Halvorsen S, Fernandez-Aviles F, Le May MR, Scheller B, Borgia F, Piscione F, Madan M, Goodman SG. Graham JJ, et al. Among authors: borgia f. Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):295-301. doi: 10.1016/j.carrev.2016.03.008. Epub 2016 Mar 28. Cardiovasc Revasc Med. 2016. PMID: 27116940
211 results